| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| ARROWHEAD PHARMACEUTICALS, INC. | Chief Commercial Officer | Common Stock | 106K | $3.95M | $37.37 | Jun 22, 2021 | Direct |
| Crinetics Pharmaceuticals, Inc. | Chief Commercial Officer | Common Stock | 29.3K | $1.29M | $44.08 | Jul 5, 2024 | Direct |
| Crinetics Pharmaceuticals, Inc. | Chief Commercial Officer | Stock option (Right to Buy) | 130K | Jul 5, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| CRNX | Crinetics Pharmaceuticals, Inc. | Jul 5, 2024 | 3 | -$365K | 4 | Jul 9, 2024 | Chief Commercial Officer |
| CRNX | Crinetics Pharmaceuticals, Inc. | Jun 21, 2024 | 3 | -$374K | 4 | Jun 24, 2024 | Chief Commercial Officer |
| CRNX | Crinetics Pharmaceuticals, Inc. | Mar 18, 2024 | 1 | -$66.4K | 4 | Mar 20, 2024 | Chief Commercial Officer |
| CRNX | Crinetics Pharmaceuticals, Inc. | Mar 4, 2024 | 2 | $0 | 4 | Mar 6, 2024 | Chief Commercial Officer |
| CRNX | Crinetics Pharmaceuticals, Inc. | Mar 1, 2023 | 2 | $0 | 4 | Mar 3, 2023 | Chief Commercial Officer |
| CRNX | Crinetics Pharmaceuticals, Inc. | Mar 10, 2022 | 1 | $0 | 4 | Mar 10, 2022 | Chief Commercial Officer |
| CRNX | Crinetics Pharmaceuticals, Inc. | Feb 28, 2022 | 0 | $0 | 3 | Mar 9, 2022 | Chief Commercial Officer |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Jun 22, 2021 | 1 | -$323K | 4 | Jun 24, 2021 | Chief Commercial Officer |